Lichen International Ltd current report, Q1 FY2023

Vollständiges Dokument

Filing Summary

Business Context and Reporting Period

Lichen China Limited filed a Form 6-K for February 2023. The filing reports the closing of the company’s initial public offering (IPO), rather than operating or quarterly financial results. The filing identifies the registrant as Lichen China Limited; the request metadata refers to Lichen International Ltd, which investors should verify.

IPO and Key Financial Metrics

  • The company sold 4,000,000 Class A ordinary shares at $4.00 per share.
  • Implied gross IPO proceeds were approximately $16.0 million before underwriting discounts, commissions, offering expenses, and other costs. The filing text does not provide net proceeds.
  • The offering was conducted on a firm-commitment basis.
  • Univest Securities, LLC acted as lead underwriter and AC Sunshine Securities LLC acted as co-underwriter.
  • The filing does not provide revenue, profit, cash flow, margins, debt, liquidity balances, or other operating metrics for the period.

Material Changes and Transaction Timeline

  • The SEC declared the company’s Form F-1 registration statement effective on February 3, 2023.
  • The Class A ordinary shares began trading on the Nasdaq Capital Market under the ticker “LICN” on February 6, 2023.
  • The IPO closed on February 8, 2023.
  • The filing does not provide a prior-period comparison or material operating changes.

Outlook, Risks, and Unusual Items

The filing does not provide management guidance, an operating outlook, or new risk disclosures. The principal unusual item is the company’s transition to a publicly traded issuer and the completion of its IPO. The filing includes customary language stating that the report is not an offer to sell or solicitation to buy securities where unlawful.

Investor Verification Points

  • Verify the registrant’s legal name and its relationship, if any, to “Lichen International Ltd.”
  • Review the Form F-1 and IPO prospectus for the use of proceeds, underwriting discounts, offering expenses, dilution, and financial statements.
  • Confirm the actual net cash proceeds received from the IPO.
  • Verify the company’s post-IPO share count, ownership structure, and Nasdaq listing status.
  • Review Exhibits 99.1 and 99.2, which contain the IPO pricing and closing press releases.